AxoGen Company Profile (NASDAQ:AXGN)

About AxoGen (NASDAQ:AXGN)

AxoGen logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AXGN
  • CUSIP: N/A
  • Web:
  • Market Cap: $509.66 million
  • Outstanding Shares: 33,095,000
Average Prices:
  • 50 Day Moving Avg: $12.56
  • 200 Day Moving Avg: $10.34
  • 52 Week Range: $5.35 - $16.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 770.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $45.24 million
  • Price / Sales: 11.27
  • Book Value: $0.37 per share
  • Price / Book: 41.62
  • EBIDTA: ($8,230,000.00)
  • Net Margins: -33.02%
  • Return on Equity: -292.94%
  • Return on Assets: -37.09%
  • Debt-to-Equity Ratio: 22.72%
  • Current Ratio: 6.24%
  • Quick Ratio: 5.16%
  • Average Volume: 194,900 shs.
  • Beta: 0.15
  • Short Ratio: 12.05

Frequently Asked Questions for AxoGen (NASDAQ:AXGN)

What is AxoGen's stock symbol?

AxoGen trades on the NASDAQ under the ticker symbol "AXGN."

How were AxoGen's earnings last quarter?

AxoGen, Inc. (NASDAQ:AXGN) posted its quarterly earnings data on Thursday, May, 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.01. The firm had revenue of $12.24 million for the quarter, compared to analysts' expectations of $11.83 million. AxoGen had a negative return on equity of 292.94% and a negative net margin of 33.02%. View AxoGen's Earnings History.

Where is AxoGen's stock going? Where will AxoGen's stock price be in 2017?

4 brokerages have issued 12 month price objectives for AxoGen's shares. Their predictions range from $11.00 to $14.50. On average, they expect AxoGen's share price to reach $13.17 in the next twelve months. View Analyst Ratings for AxoGen.

Who are some of AxoGen's key competitors?

Who owns AxoGen stock?

AxoGen's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (0.00%), Cortina Asset Management LLC (0.00%), Perkins Capital Management Inc. (1.79%), Gilder Gagnon Howe & Co. LLC (0.00%), Next Century Growth Investors LLC (0.00%) and Driehaus Capital Management LLC (1.54%). Company insiders that own AxoGen stock include Amy Mcbride Wendell, James E Flynn, John P Engels, Joseph M Mandato, Karen L Zaderej, Lee Robert Johnston Jr and Peter J Mariani. View Institutional Ownership Trends for AxoGen.

Who sold AxoGen stock? Who is selling AxoGen stock?

AxoGen's stock was sold by a variety of institutional investors in the last quarter, including EAM Investors LLC, Next Century Growth Investors LLC, Wells Fargo & Company MN, JPMorgan Chase & Co., Granite Point Capital Management L.P., Morgan Stanley, Cortina Asset Management LLC and Russell Investments Group Ltd.. Company insiders that have sold AxoGen stock in the last year include James E Flynn and Joseph M Mandato. View Insider Buying and Selling for AxoGen.

Who bought AxoGen stock? Who is buying AxoGen stock?

AxoGen's stock was bought by a variety of institutional investors in the last quarter, including Lyon Street Capital LLC, Renaissance Technologies LLC, Gilder Gagnon Howe & Co. LLC, Summit Partners Public Asset Management LLC, Vanguard Group Inc., Essex Investment Management Co. LLC, KCG Holdings Inc. and Trexquant Investment LP. Company insiders that have bought AxoGen stock in the last two years include Amy Mcbride Wendell, John P Engels, Joseph M Mandato, Karen L Zaderej, Lee Robert Johnston Jr and Peter J Mariani. View Insider Buying and Selling for AxoGen.

How do I buy AxoGen stock?

Shares of AxoGen can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of AxoGen stock cost?

One share of AxoGen stock can currently be purchased for approximately $15.40.

Analyst Ratings

Consensus Ratings for AxoGen (NASDAQ:AXGN) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.17 (14.50% downside)

Analysts' Ratings History for AxoGen (NASDAQ:AXGN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/19/2017WedbushReiterated RatingOutperform$17.00 -> $14.00HighView Rating Details
3/6/2017Roth CapitalInitiated CoverageBuy -> Buy$14.50N/AView Rating Details
11/22/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
11/22/2016Lake Street CapitalUpgradeHold -> Buy$9.00 -> $11.00N/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for AxoGen (NASDAQ:AXGN)
Earnings by Quarter for AxoGen (NASDAQ:AXGN)
Earnings History by Quarter for AxoGen (NASDAQ:AXGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017($0.10)($0.11)$11.83 million$12.24 millionViewListenView Earnings Details
2/22/2017Q4 2016($0.09)($0.10)$11.41 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.08)($0.08)$11.21 million$11.21 millionViewN/AView Earnings Details
8/3/2016Q2($0.12)($0.09)$9.28 million$10.38 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.11)$6.70 million$8.15 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.15)($0.13)$5.89 million$6.42 millionViewN/AView Earnings Details
5/5/2015Q1 2015($0.17)($0.16)$4.90 million$4.95 millionViewN/AView Earnings Details
11/13/2014Q3 2014($0.24)($0.19)$4.67 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.22)($0.21)$3.30 million$4.21 millionViewN/AView Earnings Details
4/30/2014Q1 2014($0.26)($0.24)$2.75 million$3.14 millionViewN/AView Earnings Details
3/6/2014($0.22)($0.24)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for AxoGen (NASDAQ:AXGN)
2017 EPS Consensus Estimate: ($0.25)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173($0.12)($0.07)($0.10)
Q2 20173($0.06)($0.04)($0.05)
Q3 20173($0.05)($0.03)($0.04)
Q4 20173($0.09)($0.04)($0.06)
Q1 20181$0.01$0.01$0.01
Q2 20181$0.03$0.03$0.03
Q3 20181$0.04$0.04$0.04
(Data provided by Zacks Investment Research)


Dividend History for AxoGen (NASDAQ:AXGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for AxoGen (NASDAQ:AXGN)
Insider Ownership Percentage: 9.33%
Institutional Ownership Percentage: 55.89%
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Institutional Ownership by Quarter for AxoGen (NASDAQ:AXGN)
Insider Trades by Quarter for AxoGen (NASDAQ:AXGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2016Amy Mcbride WendellDirectorBuy13,333$7.50$99,997.50View SEC Filing  
10/7/2016John P EngelsVPBuy4,000$7.50$30,000.00View SEC Filing  
10/7/2016Karen L ZaderejCEOBuy10,000$7.50$75,000.00View SEC Filing  
10/7/2016Peter J MarianiCFOBuy3,333$7.50$24,997.50View SEC Filing  
8/9/2016Joseph M MandatoDirectorSell149,618$8.54$1,277,737.72View SEC Filing  
8/8/2016Joseph M MandatoDirectorSell107,450$8.63$927,293.50View SEC Filing  
7/21/2016James E FlynnInsiderSell102,136$6.70$684,311.20View SEC Filing  
7/18/2016James E FlynnInsiderSell279,303$7.53$2,103,151.59View SEC Filing  
9/18/2015James E FlynnInsiderSell345,000$5.50$1,897,500.00View SEC Filing  
6/3/2015Joseph M MandatoDirectorBuy6,500$3.10$20,150.00View SEC Filing  
6/2/2015Lee Robert Johnston JrInsiderBuy5,000$3.06$15,300.00View SEC Filing  
4/8/2015James E FlynnInsiderSell144,385$3.25$469,251.25View SEC Filing  
12/10/2014Lee Robert Johnston JrCFOBuy10,000$3.06$30,600.00View SEC Filing  
8/12/2014Mark Stephen GoldDirectorBuy20,000$2.29$45,800.00View SEC Filing  
8/8/2014Mark Stephen GoldDirectorBuy11,000$2.31$25,410.00View SEC Filing  
6/6/2014Lee Robert Johnston JrCFOBuy10,000$2.58$25,800.00View SEC Filing  
6/3/2014Gregory Gene FreitagCFOBuy5,200$2.45$12,740.00View SEC Filing  
6/3/2014Karen L ZaderejCEOBuy5,000$2.43$12,150.00View SEC Filing  
5/20/2014Jill F SchiaparelliSVPBuy2,000$2.63$5,260.00View SEC Filing  
5/12/2014Karen L ZaderejCEOBuy5,000$2.70$13,500.00View SEC Filing  
5/7/2014Mark Stephen GoldDirectorBuy1,977$2.60$5,140.20View SEC Filing  
3/13/2014Karen L ZaderejCEOBuy1,500$3.49$5,235.00View SEC Filing  
8/29/2013Shawn F MccarreySVPBuy25,000$3.21$80,250.00View SEC Filing  
8/24/2013Shawn F MccarreySVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013Jill F SchiaparelliSVPBuy5,000$3.00$15,000.00View SEC Filing  
8/14/2013John Frederick HarperDirectorBuy66,666$3.00$199,998.00View SEC Filing  
8/14/2013Karen L ZaderejCEOBuy8,334$3.00$25,002.00View SEC Filing  
12/4/2012Jill F SchiaparelliSVPBuy2,000$2.55$5,100.00View SEC Filing  
11/29/2012Jill F SchiaparelliSVPBuy1,000$2.70$2,700.00View SEC Filing  
11/15/2012Jill F SchiaparelliSVPBuy2,750$2.56$7,040.00View SEC Filing  
10/1/2012John Frederick HarperDirectorBuy86,557$3.61$312,470.77View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for AxoGen (NASDAQ:AXGN)
Latest Headlines for AxoGen (NASDAQ:AXGN)
DateHeadline logoAxoGen's (AXGN) CEO Karen Zaderej Hosts 2017 Annual Shareholders' Meeting (Transcript) - May 25 at 2:08 AM logoAxoGen (AXGN) Shows Strength: Stock Adds 6.1% in Session - May 22 at 10:08 AM logoAxoGen (AXGN): Management Meeting Highlights New Opportunity - Wedbush - May 19 at 9:21 AM logoWedbush Reaffirms Outperform Rating for AxoGen, Inc. (AXGN) - May 19 at 7:42 AM logoETFs with exposure to AxoGen, Inc. : May 15, 2017 - May 15 at 4:16 PM logoAxoGen, Inc. :AXGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 - May 10 at 3:58 PM logoFY2019 EPS Estimates for AxoGen, Inc. Raised by Wedbush (AXGN) - May 8 at 12:12 PM logoAxoGen, Inc. (AXGN) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - May 5 at 3:58 PM logoZacks: Brokerages Anticipate AxoGen, Inc. (AXGN) to Announce -$0.05 EPS - May 5 at 2:25 PM logoAxoGen, Inc. Reports 2017 First Quarter Financial Results - May 4 at 8:55 PM logoAxoGen reports 1Q loss - May 4 at 8:55 PM logoInvestor Network: AxoGen, Inc. to Host Earnings Call - May 4 at 3:53 PM logoETFs with exposure to AxoGen, Inc. : May 2, 2017 - May 3 at 11:52 AM logoSomewhat Negative News Coverage Very Likely to Affect AxoGen (AXGN) Stock Price - May 2 at 6:10 PM logoAxoGen, Inc. (AXGN) Set to Announce Earnings on Thursday - May 2 at 10:24 AM logoSomewhat Negative News Coverage Extremely Likely to Affect AxoGen (AXGN) Stock Price - April 29 at 11:14 AM logoAxoGen (AXGN) Given News Sentiment Rating of 0.56 - April 24 at 1:00 PM logoSomewhat Positive Press Coverage Very Likely to Affect AxoGen (AXGN) Stock Price - April 21 at 11:39 AM logoAxoGen (AXGN) Earning Somewhat Positive Media Coverage, AlphaOne Reports - April 18 at 12:20 PM logoETFs with exposure to AxoGen, Inc. : April 17, 2017 - April 17 at 3:42 PM logoAxoGen, Inc. (AXGN) Short Interest Up 2.0% in March - April 17 at 10:48 AM logoAxoGen, Inc. (AXGN) Expected to Post Quarterly Sales of $11.83 Million - April 16 at 8:38 AM logoAxoGen (AXGN) Receiving Favorable Media Coverage, Report Shows - April 15 at 10:55 AM logoAxoGen, Inc. (AXGN) Expected to Announce Earnings of -$0.10 Per Share - April 14 at 4:32 PM logoAxoGen, Inc. to Report First Quarter 2017 Financial Results and Host Conference Call on Thursday, May 4, 2017 - April 14 at 11:19 AM logoAxoGen, Inc. Announces 2017 Annual Shareholders’ Meeting - April 7 at 3:44 PM logoETFs with exposure to AxoGen, Inc. : April 5, 2017 - April 7 at 8:15 AM logoAXOGEN, INC. Financials - March 7 at 3:46 PM logoCoverage initiated on AxoGen by ROTH Capital - March 7 at 9:31 AM logoAxoGen, Inc. to Present at the Oppenheimer 27th Annual Healthcare Conference - March 7 at 9:31 AM logoAxoGen, Inc. to Present at Upcoming Investor Conferences - GlobeNewswire (press release) - March 4 at 4:16 PM logoAxoGen, Inc. to Present at Upcoming Investor Conferences - March 2 at 4:00 PM logoAXOGEN, INC. Files SEC form 10-K, Annual Report - March 1 at 8:44 PM logoAxoGen reports 4Q loss - Yahoo Finance - February 23 at 1:52 AM logoAxoGen, Inc. Reports 2016 Fourth Quarter and Full Year Financial Results - February 22 at 8:50 PM logoAxoGen reports 4Q loss - February 22 at 8:50 PM logoAxoGen, Inc. to Report Fourth Quarter and 2016 Full Year Financial Results and Host Conference Call on Wednesday ... - GlobeNewswire (press release) - February 8 at 3:39 PM logoAxoGen, Inc. to Report Fourth Quarter and 2016 Full Year Financial Results and Host Conference Call on Wednesday, February 22, 2017 - February 8 at 3:39 PM logoAXOGEN, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - January 26 at 9:14 PM featured highlights: AxoGen, MAG Silver, Triumph Bancorp, UCP and Yelp - January 18 at 4:26 PM



AxoGen (AXGN) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by Staff